N3 alkylated benzimidazole derivatives as MEK inhibitors

Details for Australian Patent Application No. 2003220202 (hide)

Owner ARRAY BIOPHARMA, INC

Inventors Marlow, Allison L; Lyssikatos, Joseph P; Wallace, Eli M; Hurley, Brian T

Agent Watermark

Pub. Number AU-A-2003220202

PCT Number PCT/US03/07565

PCT Pub. Number WO2003/077855

Priority 60/364,164 13.03.02 US

Filing date 13 March 2003

Wipo publication date 29 September 2003

Event Publications

31 July 2003 Complete Application Filed

  Priority application(s): 60/364,164 13.03.02 US

6 November 2003 Application Open to Public Inspection

  Published as AU-A-2003220202

9 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003220203-A RHODOCOCCUS GENE ENCODING ALDOXIME DEHYDRATASE

2003220201-PURIFICATION AND CLONING OF NMN ADENYLYLTRANSERASE AND ITS THERAPEUTIC USE